SEMAGLUTIDE 5mg

Manufacturer: Deus Medical, Europe

Pharmaceutical name: Semaglutide

Pack: 1 vial (5 mg)

Semaglutide is a powerful once-weekly GLP-1 receptor agonist (RA) that significantly lowers HbA1c, body weight, and systolic blood pressure. Nevertheless, it is linked to a higher occurrence of gastrointestinal side effects. The findings regarding pancreatitis and retinopathy need further investigation in post-marketing surveillance studies.

 

Semaglutide is classified as a glucagon-like peptide-1 receptor agonist (GLP-1 RA), which imitates the GLP-1 hormone released by the gut in response to food intake.

 

One function of GLP-1 is to stimulate the pancreas to release more insulin, leading to lower blood glucose levels. For this reason, Semaglutide has been utilized for over 15 years to manage Type 2 diabetes.

 

At higher levels, GLP-1 also affects brain regions that control appetite suppression and convey the sensation of fullness. When combined with a healthy diet and exercise, it can lead to substantial weight loss, as well as a decreased likelihood of cancer, diabetes, and heart disease in individuals who are overweight or obese.

 

The side effects associated with semaglutide are generally mild, particularly when compared to the health risks tied to being overweight and obese.

 

Those using semaglutide for weight loss might encounter:

Dizziness

Fatigue

Gastrointestinal disturbances, including diarrhea, constipation, and gas

Headaches

Stomach problems such as nausea, vomiting, pain, or bloating

Gastrointestinal issues are the most frequently reported complaints among new users of semaglutide. However, starting with a lower dose and gradually increasing it may help minimize these side effects.